https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
A new study led by the University of Miami Miller School of Medicine’s Kirill Martemyanov, Ph.D., and international collaborators highlights a new approach to treating depression that bypasses many limitations of traditional antidepressants. The team has developed a highly selective protein-based biologic called a nanobody that targets a newly discovered brain receptor implicated in depression.
